Prometheus Therapeutics Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Apr 15, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Nov 12, 2025 · D | Apr 15, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $5,000,000 | $6,500,000 | $1,500,000 |
| Reported amount sold | $130,000 | $2,745,000 | $2,615,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001823161-25-000002 · Later SEC source: 0001823161-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $6,500,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $2,745,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Deinde Medical Corp. · CIK 1795076
- NeuroFine Corp. · CIK 1888692
Form D filings (2)
-
0001823161-26-000001D/A · Apr 15, 2026 · Other Health CareOffering: $6,500,000Sold: $2,745,000
Compared with 0001823161-25-000002:
- Reported offering amount: $5,000,000 → $6,500,000
- Reported amount sold: $130,000 → $2,745,000
-
0001823161-25-000002D · Nov 12, 2025 · Other Health CareOffering: $5,000,000Sold: $130,000